KEY vs PACB · P/E 13, rev $7.51B vs rev $38.4M
KeyCorp (KEY) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. PACB currently screens at market cap $387.1M.
Not investment advice. Open the KEY and PACB stock pages for the full models.
Not investment advice.